Daliresp 250 ug/1

Daliresp 250 µg tablets contain roflumilast, a medication used to manage chronic obstructive pulmonary disease (COPD). This oral treatment helps reduce inflammation in the lungs, aiding in symptom management. Learn more about roflumilast and its uses here.

Daliresp 250 µg tablets are primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Roflumilast, the active ingredient, works by reducing inflammation in the lungs, which can help improve breathing and reduce flare-ups. This medication is often prescribed for individuals with severe COPD who experience frequent exacerbations. What is Daliresp used for? It is designed to manage symptoms and improve quality of life for those with this chronic condition.

Common effects of Daliresp 250 µg tablets may include headaches, diarrhea, nausea, and weight loss. Some individuals might also experience insomnia or dizziness. These effects vary from person to person and are not experienced by everyone who takes the medication. If any effects are severe or persistent, it is important to consult a healthcare provider.

Daliresp 250 µg tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Daliresp 250 µg tablets may interact with other medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, certain foods or supplements may also interact with roflumilast, so it is advisable to consult a healthcare professional for personalized advice.